Eritrea vs Lower-middle income (World Bank): HIV-positive TB patients on ART (antiretroviral therapy)
Eritrea
100.0%
in 2024
Lower-middle income (World Bank)
95.0%
in 2024
Eritrea rank
1st
Lower-middle income (World Bank) rank
3rd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Eritrea
- Lower-middle income (World Bank)
How they compare
Eritrea currently reports 100.0% against 95.0% in Lower-middle income (World Bank), a difference of 5.0%.
That makes Eritrea's figure about 1.1 times Lower-middle income (World Bank)'s.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was Lower-middle income (World Bank) ahead.
Eritrea ranks 1st and Lower-middle income (World Bank) ranks 3rd of 144 countries.
Across the 2 decades both report, Eritrea averaged higher in 1 and Lower-middle income (World Bank) in 1.
Head to head by decade
| Decade | Eritrea | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.1% | 85.0% | 2.9% | Lower-middle income (World Bank) |
| 2020s | 98.2% | 94.0% | 4.2% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Eritrea or Lower-middle income (World Bank)?
- Eritrea, at 100.0% against 95.0% in Lower-middle income (World Bank) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Eritrea and Lower-middle income (World Bank)?
- 5.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Lower-middle income (World Bank)?
- 12 years are reported by both, from 2013 to 2024.
- How do Eritrea and Lower-middle income (World Bank) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Eritrea ranks 1st and Lower-middle income (World Bank) ranks 3rd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.